Selected article for: "bacterial infection and MxA crp"
Author: Joseph, Patrick; Godofsky, Eliot
Title: Outpatient Antibiotic Stewardship: A Growing Frontier—Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use
  • Document date: 2018_2_15
    • ID: 0emio4rl_6
    Snippet: Efficiently defining a clinically significant bacterial infection requiring antibiotic therapy is the rate-limiting step of antibiotic stewardship in the outpatient setting. Biomarkers such as C-reactive protein (CRP) or procalcitonin (PCT) independently may identify clinically significant infections, thereby reducing the risk of missing a clinically significant bacterial infection. However, these biomarkers lack adequate specificity to different.....
    Document: Efficiently defining a clinically significant bacterial infection requiring antibiotic therapy is the rate-limiting step of antibiotic stewardship in the outpatient setting. Biomarkers such as C-reactive protein (CRP) or procalcitonin (PCT) independently may identify clinically significant infections, thereby reducing the risk of missing a clinically significant bacterial infection. However, these biomarkers lack adequate specificity to differentiate a viral from a bacterial infection and ultimately lead to antibiotic overtreatment of viral infections. Myxovirus resistance protein A (MxA), a protein induced by type I interferon, is selectively elevated in patients with viral infections and has the potential to greatly enhance the rapid distinction between viral and bacterial respiratory infections [7, 8] . Combining CRP or PCT with an elevated MxA will help identify patients who most likely have viral infection, allowing physicians to consider reserving antibiotics in this patient population and proceed with a watchful, waiting strategy.

    Search related documents:
    Co phrase search for related documents
    • antibiotic stewardship and bacterial infection viral: 1, 2, 3, 4, 5, 6, 7
    • antibiotic stewardship and bacterial viral respiratory infection: 1, 2
    • antibiotic stewardship and clinically significant bacterial infection: 1, 2, 3
    • antibiotic stewardship and clinically significant infection: 1, 2, 3
    • antibiotic stewardship and clinically significant infection identify: 1, 2
    • antibiotic therapy and bacterial infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibiotic therapy and bacterial infection viral: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antibiotic therapy and clinically significant infection: 1
    • antibiotic therapy and elevated MxA: 1
    • bacterial infection and clinically significant bacterial infection: 1, 2, 3, 4, 5, 6, 7
    • bacterial infection and clinically significant infection: 1, 2, 3, 4, 5, 6, 7
    • bacterial infection and clinically significant infection identify: 1, 2, 3
    • bacterial infection and elevated MxA: 1
    • bacterial infection viral and clinically significant bacterial infection: 1, 2, 3, 4, 5, 6
    • bacterial infection viral and clinically significant infection: 1, 2, 3, 4, 5
    • bacterial infection viral and clinically significant infection identify: 1, 2, 3
    • bacterial infection viral and elevated MxA: 1
    • bacterial infection viral differentiate and clinically significant bacterial infection: 1
    • bacterial infection viral differentiate and clinically significant infection: 1